Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated to v3.7.0, replacing the previous v3.6.6 in the site's revision history.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page’s revision tag was updated from v3.6.5 to v3.6.6, indicating a site update. This update does not alter the study details or public content displayed on the page.SummaryDifference0.0%

- Check36 days agoChange DetectedThe page’s revision label was updated from v3.6.4 to v3.6.5, indicating a backend/template update. No study content or user-facing information is altered.SummaryDifference0.0%

- Check43 days agoChange DetectedThe study's list of participating centers was updated. Cooperman Barnabas Medical Center and UPMC Hillman Cancer Center were added as sites, while Saint Barnabas Medical Center and the University of Pittsburgh Cancer Institute (UPCI) were removed.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now shows revision v3.6.4, replacing the previous revision v3.6.3, indicating an updated page version.SummaryDifference0.0%

- Check71 days agoChange DetectedLahey Hospital and Medical Center was removed on 2026-06-12 and two Lahey Clinic locations were added on 2026-07-01 and 2026-07-02, reflecting an update to the study's site listings.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.